Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ZYME Zymeworks > Detailed Quotes

ZYME Zymeworks

5.460
+0.190+3.61%
Trading Session 09/26 11:50 ET
High
5.600
Open
5.260
Turnover
981.38K
Low
5.230
Pre Close
5.270
Volume
179.81K
Market Cap
336.85M
P/E(TTM)
Loss
52wk High
29.160
Shares
61.69M
P/E(Static)
Loss
52wk Low
4.110
Float Cap
228.91M
Bid/Ask %
40.00%
Historical High
59.030
Shs Float
41.93M
Volume Ratio
1.03
Historical Low
4.110
Dividend TTM
--
Div Yield TTM
100
P/B
1.52
Dividend LFY
--
Div Yield LFY
1831.50%
Turnover Ratio
0.43%
Amplitude
7.02%
Avg Price
5.457
Lot Size
1
Float Cap
228.91M
Bid/Ask %
40.00%
Historical High
59.030
Shs Float
41.93M
Volume Ratio
1.03
Historical Low
4.110
Dividend TTM
--
P/B
1.52
Dividend LFY
--
Turnover Ratio
0.43%
Amplitude
7.02%
Avg Price
5.457
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Zymeworks, Inc. is a clinical-stage biopharmaceutical company, engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.
CEO: Mr. Kenneth Galbraith
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...